Investigations into the burning-out of organic substances in the ceramic body

Pressed compacts were made of spray dried alumina containing water soluble polyvinyl alcohol or cellulose derivative binder. The burning out of organic binder on gradual heating was investigated by visual and microscopic observations of the cross section and by thermogravimetry. Burning out proceeds inward from the peripheries, gradually reducing the size of the black core, which first consists of a dark boundary layer and later turns uniformly black with a sharp boundary. A detailed mechanism of the burning out process between and within the spray dried granules is observed under the microscope. Oxygen atmosphere accelerates the burning out process

China clay waste as aggregate in AA cement mortars

Every 1 t of china clay produced in the UK generates 9 t of waste material. A limited quantity of the coarser waste has beneficial use as a building stone or secondary aggregate in concrete and asphalt, but there are currently limited uses for the finest waste fraction. ‘Mica’ waste is a mixture of fine minerals and is one of the forms of waste with little beneficial use other than the restoration of old quarries. With an aim to find new commercially viable and low environmental impact uses in construction, this paper focuses on the use of china clay waste as an aggregate in alkali-activated cement mortar. Based on preliminary analysis of the compressive strength of binders using slag and fly ash, optimum binders were selected to produce mortars using mica and other forms of china clay waste as aggregate. The mortars were then compared in compression with control specimens using standard sand. Although the results show that the test mortars were generally weaker than the control samples, the paper concludes there are opportunities for their use. </jats:p

Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region

Effective public health measures against SARS-CoV-2 require granular knowledge of population-level immune responses. We developed a Tripartite Automated Blood Immunoassay (TRABI) to assess the IgG response against three SARS-CoV-2 proteins. We used TRABI for continuous seromonitoring of hospital patients and blood donors (n = 72'250) in the canton of Zurich from December 2019 to December 2020 (pre-vaccine period). We found that antibodies waned with a half-life of 75 days, whereas the cumulative incidence rose from 2.3% in June 2020 to 12.2% in mid-December 2020. A follow-up health survey indicated that about 10% of patients infected with wildtype SARS-CoV-2 sustained some symptoms at least twelve months post COVID-19. Crucially, we found no evidence of a difference in long-term complications between those whose infection was symptomatic and those with asymptomatic acute infection. The cohort of asymptomatic SARS-CoV-2-infected subjects represents a resource for the study of chronic and possibly unexpected sequelae

STXBP1 promotes Weibel-Palade body exocytosis through its interaction with the Rab27A effector Slp4-a.

Vascular endothelial cells contain unique rod-shaped secretory organelles, called Weibel-Palade bodies (WPBs), which contain the hemostatic protein von Willebrand factor (VWF) and a cocktail of angiogenic and inflammatory mediators. We have shown that the Rab27A effector synaptotagmin-like protein 4-a (Slp4-a) plays a critical role in regulating hormone-evoked WPB exocytosis. Using a nonbiased proteomic screen for targets for Slp4-a, we now identify syntaxin-binding protein 1 (STXBP1) and syntaxin-2 and -3 as endogenous Slp4-a binding partners in endothelial cells. Coimmunoprecipitations showed that STXBP1 interacts with syntaxin-2 and -3, but not with syntaxin-4. Small interfering RNA-mediated silencing of STXBP1 expression impaired histamine- and forskolin-induced VWF secretion. To further substantiate the role of STXBP1, we isolated blood outgrowth endothelial cells (BOECs) from an early infantile epileptic encephalopathy type 4 (EIEE4) patient carrying a de novo mutation in STXBP1. STXBP1-haploinsufficient EIEE4 BOECs contained similar numbers of morphologically normal WPBs compared with control BOECs of healthy donors; however, EIEE4 BOECs displayed significantly impaired histamine- and forskolin-stimulated VWF secretion. Based on these findings, we propose that the Rab27A-Slp4-a complex on WPB promotes exocytosis through an interaction with STXBP1, thereby controlling the release of vaso-active substances in the vasculature

Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders

As B cells differentiate into antibody-secreting cells (ASCs), short-lived plasmablasts (SLPBs) are produced by a primary extrafollicular response, followed by the generation of memory B cells and long-lived plasma cells (LLPCs) in germinal centers (GCs). Generation of IgG4 antibodies is T helper type 2 (Th2) and IL-4, -13, and -10-driven and can occur parallel to IgE, in response to chronic stimulation by allergens and helminths. Although IgG4 antibodies are non-crosslinking and have limited ability to mobilize complement and cellular cytotoxicity, when self-tolerance is lost, they can disrupt ligand-receptor binding and cause a wide range of autoimmune disorders including neurological autoimmunity. In myasthenia gravis with predominantly IgG4 autoantibodies against muscle-specific kinase (MuSK), it has been observed that one-time CD20+ B cell depletion with rituximab commonly leads to long-term remission and a marked reduction in autoantibody titer, pointing to a short-lived nature of autoantibody-secreting cells. This is also observed in other predominantly IgG4 autoantibody-mediated neurological disorders, such as chronic inflammatory demyelinating polyneuropathy and autoimmune encephalitis with autoantibodies against the Ranvier paranode and juxtaparanode, respectively, and extends beyond neurological autoimmunity as well. Although IgG1 autoantibody-mediated neurological disorders can also respond well to rituximab induction therapy in combination with an autoantibody titer drop, remission tends to be less long-lasting and cases where titers are refractory tend to occur more often than in IgG4 autoimmunity. Moreover, presence of GC-like structures in the thymus of myasthenic patients with predominantly IgG1 autoantibodies against the acetylcholine receptor and in ovarian teratomas of autoimmune encephalitis patients with predominantly IgG1 autoantibodies against the N‐methyl‐d‐aspartate receptor (NMDAR) confers increased the ability to generate LLPCs. Here, we review available information on the short-and long-lived nature of ASCs in IgG1 and IgG4 autoantibody-mediated neurological disorders and highlight common mechanisms as well as differences, all of which can inform therapeutic strategies and personalized medical approaches. © Copyright © 2021 Zografou, Vakrakou and Stathopoulos

INFLUENCE OF Al - PRECURSORS ON THE REACTION - SINTERING OF ZIRCONIA - MULLITE COMPOSITES

Sur la base de la réaction zircon + alumine → zircone + mullite, on a examiné l'influence de différents précurseurs industriels d'aluminium sur le développement des phases, la densité et la microstructure aux températures élevées. La densification dépend fortement de la nature et de la réactivité des alumines utilisées de même que de l'avancement de la réaction. Il est possible d'obtenir des composites mullite-zircone denses, à granulométrie fine pour des applications réfractaires par les techniques de fabrication conventionnelles.On the base of the reaction zircon + alumina → zirconia + mullite, the influence of different industrial Al-precursors on phase development, density and microstructure at elevated temperatures was investigated. Densification depends strongly on the nature and reactivity of the aluminas used, as well as on the extent of reaction progress. It is possible to obtain dense, fine grained zirconia-mullite composites for refractory applications by conventional fabrication techniques